Gradignan, France

Pierre Tchoreloff

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Bures sur Yvette, FR (2011 - 2012)
  • Gradignan, FR (2023)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Pierre Tchoreloff: Innovator in Nucleic Acid and Mucoadhesive Technologies

Introduction

Pierre Tchoreloff is a notable inventor based in Gradignan, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 4 patents to his name, Tchoreloff's work has the potential to impact various medical applications.

Latest Patents

Among his latest patents, Tchoreloff has developed a process for the manufacture of nucleic acid vector tablets. This invention relates to a tablet that comprises a nucleic acid vector, which can be crucial for gene therapy applications. Additionally, he has created a mucoadhesive sustained-release vaginal tablet that includes at least one probiotic strain. This tablet is designed with an excipient that confers properties of mucoadhesion to the vaginal wall and allows for sustained release, enhancing its therapeutic effectiveness.

Career Highlights

Throughout his career, Pierre Tchoreloff has worked with reputable organizations such as Ethypharm, Inc. and Université De Bordeaux. His experience in these institutions has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.

Collaborations

Tchoreloff has collaborated with notable colleagues, including Bernard Leclerc and Guy Couaraze. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Pierre Tchoreloff's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical technology. His work in nucleic acid and mucoadhesive technologies holds promise for future developments in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…